|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
21
|
|
pubmed:dateCreated |
1999-12-14
|
|
pubmed:abstractText |
Intravenous tissue-type plasminogen activator can be beneficial to some patients when given within 3 hours of stroke onset, but many patients present later after stroke onset and alternative treatments are needed.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0098-7484
|
|
pubmed:author |
pubmed-author:AhujaAA,
pubmed-author:CallahanFF,
pubmed-author:ClarkW MWM,
pubmed-author:FurlanAA,
pubmed-author:GentMM,
pubmed-author:HigashidaRR,
pubmed-author:KaskEE,
pubmed-author:PessinMM,
pubmed-author:RiveraFF,
pubmed-author:RowleyHH,
pubmed-author:SilverFF,
pubmed-author:WechslerLL
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
282
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
2003-11
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:10591382-Aged,
pubmed-meshheading:10591382-Brain Ischemia,
pubmed-meshheading:10591382-Cerebral Angiography,
pubmed-meshheading:10591382-Female,
pubmed-meshheading:10591382-Fibrinolytic Agents,
pubmed-meshheading:10591382-Heparin,
pubmed-meshheading:10591382-Humans,
pubmed-meshheading:10591382-Infarction, Middle Cerebral Artery,
pubmed-meshheading:10591382-Infusions, Intra-Arterial,
pubmed-meshheading:10591382-Intracranial Hemorrhages,
pubmed-meshheading:10591382-Male,
pubmed-meshheading:10591382-Middle Aged,
pubmed-meshheading:10591382-Neurologic Examination,
pubmed-meshheading:10591382-Recombinant Proteins,
pubmed-meshheading:10591382-Severity of Illness Index,
pubmed-meshheading:10591382-Survival Analysis,
pubmed-meshheading:10591382-Thrombolytic Therapy,
pubmed-meshheading:10591382-Time Factors,
pubmed-meshheading:10591382-Tomography, X-Ray Computed,
pubmed-meshheading:10591382-Treatment Outcome,
pubmed-meshheading:10591382-Urokinase-Type Plasminogen Activator
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.
|
|
pubmed:affiliation |
Cerebrovascular Center, Department of Neurology, Cleveland Clinic Foundation, Ohio 44195, USA. furlana@ccf.org
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
